Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

Earlier this year, NMD4C, MDC and Quebec SMA Network hosted the first interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal Muscular Atrophy (SMA).

To complement this training session, the NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures.

This workshop will be taking place the day before the Allied Professionals Forum in Montreal.

Please ensure you register before the deadline of June 18th, 2024.

Please ensure that you meet the eligibility criteria:

  • Must be a physiotherapist or occupational therapist at a Canadian institution/clinic evaluating patients of any age with SMA.
  • Must be a NMD4C member.

Disclaimer:

We have a limited number of seats available for this workshop (in-person only). Participants will be selected based on considerations related to geography, case load and clinic needs. There is a discounted hotel room rate as part of the Allied Professionals Forum meeting and financial support for travel and accommodations will be provided (details to follow upon acceptance).

Register Here!

Spinal muscular atrophy outcome measures training registration open for December 3rd event.

Read next...

BSTC logo

Call for Applications: Join the NMD4C Basic Science Trainee Committee (BSTC)

We are thrilled to announce that the Applications are now open to Join our Basic Science Trainee Committee (BSTC) The Neuromuscular Disease Network for Canada (NMD4C) is inviting applications for our Basic Science Trainee Committee (BSTC) from trainees who are interested in contributing to national initiatives that support the neuromuscular research, clinical, and trainee communities. We…

BSTC logo

BSTC Launches Standard Operating Procedures (SOPs)

We’re pleased to announce the launch of the BSTC Standard Operating Procedures (SOPs), now available through the NMD4C Resource Hub. These SOPs provide standardized guidance for laboratories, clinics, and research programs across Canada, supporting consistent, high-quality neuromuscular care and research. Explore the full SOP Library and other open-access resources designed to advance collaboration and strengthen practices nationwide.

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Nov 26-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!